3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
9
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Multiple Myeloma
3
Down Syndrome
3
Lymphoma, Mantle-Cell
2
Leukemia, Biphenotypic, Acute
2
Smoldering Multiple Myeloma
1
Neoplasms
1
Lung Neoplasms
1
Leukemia, Plasma Cell
1
Immunoglobulin Light-chain Amyloidosis
1
Dyspnea
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Specimen Handling
6
Nuclear Medicine Department, Hospital
6
Magnetic Resonance Spectroscopy
6
X-Rays
5
Temozolomide
5
Phantoms, Imaging
5
Biopsy
5
Irinotecan
4
dinutuximab
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Cyclophosphamide
2
trametinib
1
tazemetostat
1
talazoparib
1
sargramostim
1
saponin QA-21V1
1
palbociclib
1
lutetium Lu 177 dotatate
1
irinotecan sucrosofate
1
fludarabine phosphate
1
fludarabine
1
dabrafenib
1
Vincristine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neuroblastoma
×
dexamethasone 21-phosphate
×
30 days
×
Clear all
No trials found.